Literature DB >> 7888116

The regulation of HIV by retinoic acid correlates with cellular expression of the retinoic acid receptors.

K Yamaguchi1, J E Groopman, R A Byrn.   

Abstract

OBJECTIVES: To analyze the effect of retinoic acids (RA) on HIV-1 expression and correlate this effect with expression levels of RA receptors (RARs) in T-lymphoid and monocytoid cell lines. DESIGN AND METHODS: The effect of all-trans and 9-cis RA on HIV-1 production in T-lymphoid (H9, CEM) and monocytoid (U937,THP-1) cell lines was measured during acute and chronic infection. The expression levels of human RAR alpha (hRAR alpha, receptor for all-trans RA) and the human retinoid-X receptor alpha (hRXR alpha receptor for 9-cis RA) were determined by Northern blot analysis.
RESULTS: Both all-trans and 9-cis RA inhibited virus replication in HIV-1 IIIB-infected monocytoid cells, in the presence and absence of the co-stimulatory agent phorbol myristate acetate (PMA). The retinoids had weak or no stimulatory effects on HIV production by T-cell lines. HIV production by PMA-stimulated T-cell lines was inhibited by these retinoids. The 9-cis RA was generally more effective than all-trans RA in inhibiting HIV production and in combination generally more effective than the single agents alone. Human RAR alpha was expressed in H9, U937 and THP-1 cells, but almost undetectable in CEM cells. Human RXR alpha was significantly expressed in U937 and THP-1 cells, weakly expressed in H9 cells and not detectable in CEM cells. After stimulation by PMA, RXR alpha expression increased in H9 and U937 cells but not in CEM cells. Human RAR alpha expression was unchanged in H9 and CEM cells, and elevated in U937 cells, after PMA stimulation.
CONCLUSION: The effect of RA on HIV-1 expression was cell-type-dependent and partially correlated with cellular expression of RARs. Endogenous or exogenously administered RA may have a significant role in HIV regulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7888116     DOI: 10.1097/00002030-199412000-00006

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  9 in total

1.  Retinoic acid imprints a mucosal-like phenotype on dendritic cells with an increased ability to fuel HIV-1 infection.

Authors:  Natalia Guerra-Pérez; Ines Frank; Filippo Veglia; Meropi Aravantinou; Diana Goode; James L Blanchard; Agegnehu Gettie; Melissa Robbiani; Elena Martinelli
Journal:  J Immunol       Date:  2015-01-26       Impact factor: 5.422

2.  Vitamin A deficiency and behavioral and motor deficits in the human immunodeficiency virus type 1 transgenic rat.

Authors:  Harry L June; Andrew Rong Song Tzeng Yang; Joseph L Bryant; Odell Jones; Walter Royal
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

3.  Human immunodeficiency virus type 1 induces expression of complement factors in human astrocytes.

Authors:  C Speth; G Stöckl; I Mohsenipour; R Würzner; H Stoiber; C Lass-Flörl; M P Dierich
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Retinoid-induced mu opioid receptor expression by phytohemagglutinin-stimulated U937 cells.

Authors:  Walter Royal; Michelle V Leander; Reid Bissonnette
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

5.  Retinoid-induced repression of human immunodeficiency virus type 1 core promoter activity inhibits virus replication.

Authors:  J W Maciaszek; S J Coniglio; D A Talmage; G A Viglianti
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

6.  A vitamin A deficient diet enhances proinflammatory cytokine, Mu opioid receptor, and HIV-1 expression in the HIV-1 transgenic rat.

Authors:  Walter Royal; Huiyun Wang; Odell Jones; Hieu Tran; Joseph L Bryant
Journal:  J Neuroimmunol       Date:  2007-02-07       Impact factor: 3.478

7.  Retinoid-dependent restriction of human immunodeficiency virus type 1 replication in monocytes/macrophages.

Authors:  Timothy M Hanley; Heather L B Kiefer; Aletta C Schnitzler; Jennifer E Marcello; Gregory A Viglianti
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

8.  HSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target.

Authors:  Elena Martinelli; Hugo Tharinger; Ines Frank; James Arthos; Michael Piatak; Jeffrey D Lifson; James Blanchard; Agegnehu Gettie; Melissa Robbiani
Journal:  PLoS Pathog       Date:  2011-06-30       Impact factor: 6.823

9.  Retinoic acid and liver X receptor agonist synergistically inhibit HIV infection in CD4+ T cells by up-regulating ABCA1-mediated cholesterol efflux.

Authors:  Hong Jiang; Yunden Badralmaa; Jun Yang; Richard Lempicki; Allison Hazen; Ven Natarajan
Journal:  Lipids Health Dis       Date:  2012-07-09       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.